Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The U.S. Food and Drug Administration said it would hold a public hearing seeking information and comment on the use of products labeled 'homeopathic', as well as the agency's regulatory framework for such products.
The hearing, scheduled for April 20-21, will discuss prescription drugs, biological products, and over-the-counter drugs labeled homeopathic, a market that has expanded to become a multimillion dollar industry in the United States.
The agency is set to evaluate its regulatory framework for homeopathic products after a quarter century.
An Australian government study released this month concluded that homeopathy does not work.
The FDA issued a warning earlier this month asking consumers not to rely on asthma products labeled homeopathic that are sold over the counter.
Homeopathic medicines include pellets placed under the tongue, tablets, liquids, ointments, sprays and creams.
The basic principles of homeopathy, formulated by German physician Samuel Hahnemann in the late 18th century, are based on a theory that a disease can be treated using small doses of natural substances that in a healthy person would produce symptoms of the disease.
The agenda for the hearing will be posted soon, the FDA said on Tuesday.
One can only hope
HACKERS03.18.15
China Reveals Its Cyberwar Secrets
In an extraordinary official document, Beijing admits it has special units to wage cyberwar—and a lot of them. Is anybody safe?
A high-level Chinese military organization has for the first time formally acknowledged that the country’s military and its intelligence community have specialized units for waging war on computer networks.
China’s hacking exploits, particularly those aimed at stealing trade secrets from U.S. companies, have been well known for years, and a source of constant tension between Washington and Beijing. But Chinese officials have routinely dismissed allegations that they spy on American corporations or have the ability to damage critical infrastructure, such as electrical power grids and gas pipelines, via cyber attacks.
Now it appears that China has dropped the charade. “This is the first time we’ve seen an explicit acknowledgement of the existence of China’s secretive cyber-warfare forces from the Chinese side,” says Joe McReynolds, who researches the country’s network warfare strategy, doctrine, and capabilities at the Center for Intelligence Research and Analysis.
McReynolds told The Daily Beast the acknowledgement of China’s cyber operations is contained in the latest edition of an influential publication, The Science of Military Strategy, which is put out by the top research institute of the People’s Liberation Army and is closely read by Western analysts and the U.S. intelligence community. The document is produced “once in a generation,” McReynolds said, and is widely seen as one of the best windows into Chinese strategy. The Pentagon cited the previous edition (PDF), published in 1999, for its authoritative description of China’s “comprehensive view of warfare,” which includes operations in cyberspace.
“This study is a big deal when it’s released,” McReynolds said, and the current edition marks “the first time they’ve come out and said, ‘Yes, we do in fact have network attack forces, and we have teams on both the military and civilian-government sides,’” including inside China’s equivalents of the CIA and the FBI.
The acknowledgment could have political and diplomatic implications for China’s relationship with the United States and other Western powers.
“It means that the Chinese have discarded their fig leaf of quasi-plausible deniability,” McReynolds said. “As recently as 2013, official PLA [People’s Liberation Army] publications have issued blanket denials such as, ‘The Chinese military has never supported any hacker attack or hacking activities.’ They can’t make that claim anymore.”
U.S. officials have spent years marshaling evidence of China’s cyber capabilities and have been escalating efforts to stop cyber spying. Last year, the Justice Department took the unprecedented step of indicting five Chinese military officials for hacking into U.S. companies and stealing their proprietary information to give Chinese firms a leg up on the global market.
That indictment was met with more denials, which have continued even past the publication of the latest Science of Military Strategy, which has taken months to translate, McReynolds said, and has not been publicized outside the ranks of China analysts.
“When asked, the Chinese as recently as a month ago denied they had a cyber command,” James Lewis, a senior fellow at the Center for Strategic Studies and a leading expert on China’s cyber capabilities, told The Daily Beast. Lewis said that the new revelations won’t come as “earth-shattering” to analysts and experts who closely follow statements by Chinese officials, because “we all assumed they were lying.”
“But it’s interesting, and people outside the community won’t know it,” Lewis said. He compared the revelation to China’s testing, in 2007, of an anti-satellite missile, “which came after they had for years stoutly denied that they were building space weapons.”
China has divided its cyber warfare forces into three types, said McReynolds, whose analysis is included in his forthcoming book, China’s Evolving Military Strategy, which will be published in October.
First, there are what the Chinese call “specialized military network warfare forces” consisting of operational military units “employed for carrying out network attack and defense,” McReynolds said.
Second, China has teams of specialists in civilian organizations that “have been authorized by the military to carry out network warfare operations.” Those civilian organizations include the Ministry of State Security, or MSS, which is essentially China’s version of CIA, and the Ministry of Public Security (its FBI).
Finally, there are “external entities” outside the government “that can be organized and mobilized for network warfare operations,” McReynolds said.
As to which of those groups is responsible for targeting American companies to steal their secrets, the short answer, says McReynolds: “They all do it.” Espionage by the PLA has been extensively documented, McReynolds said. And a Chinese hacking unit dubbed Axiom that has been linked to intrusions against Fortune 500 companies, journalists, and pro-democracy groups is reportedly an MSS actor. He noted that there are also many ways that Chinese civilians have been seen assisting in industrial espionage, including through “hack-for-cash” operations.
Based on other PLA writings, it appears that the military would most likely handle any targeting of critical infrastructure, McReynolds said.
Now that China is coming clean about its cyber warfare forces, other countries may question whether they can safely cooperate with the government on combating cybercrime. The Ministry of Public Security (MPS), for instance, has assisted more than 50 countries with investigations of more than a thousands cases of cybercrime over the past decade, and China has set up bilateral law enforcement cooperation with more than 30 countries, including the United States, the United Kingdom, Germany, and Russia, McReynolds said.
“With the Chinese now explicitly acknowledging that the [ministry] has network warfare forces stationed within it, the United States and other targets of Chinese state-sponsored hacking will have to weigh carefully whether cooperation with the MPS on cybercrime is worth the risks,” he said.
McReynolds also saw signs of a potential power struggle between the People’s Liberation Army and civilian government agencies like the Ministry of Public Security over who really runs cyber operations within the Chinese system. Those civilian cyber forces operated under the PLA’s “authorization,” according to the Chinese document.
“As unprecedented as it is to have the Chinese military acknowledge the existence of its network attack forces, having the PLA announce the existence of such secretive forces inside the civilian government is particularly unusual, and strikes me as an attempt to ‘plant the flag’ for the PLA,” McReynolds says.
The new analysis of China’s cyber operations has taken a long time to produce, in part because the latest edition of the The Science of Military Strategy wasn’t released until December 2013, McReynolds said. “It takes a while for this sort of information to filter out into the Western PLA-watcher community, especially since there’s no English translation available yet. It was only last summer that the first of us in the community started to obtain copies of the new SMS and go through its contents; it’s hundreds of pages long.”
McReynolds, who said he reads Chinese, also ran his translations by analysts fluent in the language to ensure the accuracy of his work, he said.
China isn’t the only major U.S. adversary with advanced military cyber operations. Russia is a “near peer” to the United States, former National Security Agency Director and Cyber Command chief General Keith Alexander said in 2010. The country’s use of cyber offensive operations has been documented both in Georgia in 2008 and more recently with Russia’s invasion of Crimea in 2014. Those operations, conducted in tandem with traditional combat operations, have been aimed at disrupting adversaries’ communications systems, including public websites.
Experts generally agree that Russia, China, and the United States have the most advanced and sophisticated cyber warfare forces. But Iran has been quickly gaining new capabilities and demonstrated a willingness to use them, as with a massive attack on U.S. bank websites in 2012. North Korea has also ramped up its cyber operations, most notably with the hacking of Sony Pictures Entertainment last year, which prompted the Obama administration to impose new economic sanctions on the hermit kingdom.
Eric Rosenbach, an assistant secretary of defense in charge of homeland defense and global security isssues, has said that some five dozen countries are building a military-cyber operation, equivalent to the United States’ Cyber Command.
March 18, 2015 The Senate Intelligence Committee released late Tuesday the language of its recently passed cybersecurity bill, which its backers say could hit the Senate floor as soon as April.
The text of the legislation—which the committee passed 14-1 last Thursday—is largely the same as the discussion drafts that circulated before the vote, but it does incorporate a number of privacy-related amendments that were offered during the markup.
Despite the changes, privacy advocates indicated they still worried the measure could lead to more spying on Americans by the National Security Agency.
The Cybersecurity Information Sharing Act is intended to help forestall cyberattacks like the one that crippled Sony Pictures last year, but concerns about government surveillance prevented a similar measure from earning a vote on the Senate floor in the last Congress. The legislation creates a voluntary framework for the private sector to share more computer data with the government by offering companies expanded legal liability if they choose to participate.
"This legislation protects the privacy rights of Americans while also minimizing our vulnerability to cyber-attacks," Senate Intelligence Committee Chairman Richard Burr said in a statement Wednesday. "Information sharing is purely voluntary and companies can only share cyber-threat information and the government may only use shared data for cybersecurity purposes."
Thanks to an extended spate of high-profile hacks, the bipartisan measure could earn an expedited review and land on the Senate floor as soon as April. In the House, Homeland Security Committee Chairman Michael McCaul signaled on Tuesday he plans to introduce his own information-sharing bill this week.
The White House has identified information-sharing as a key priority this year, although it has yet to say if it supports the current CISA language. President Obama issued a veto threat for a similar measure that passed the House a few years ago, partly because of privacy concerns.
"We are committed to working with Congress to craft legislation that reflects that balance, and can pass both houses," a senior administration official said in a statement. "In that spirit, we thank the committee for working with us to address some of the administration's most significant concerns with the committee's bill, and look forward to reviewing the legislation."
Among the nuanced changes, the latest iteration of CISA grants liability protection for companies that share information related to "defensive measures" used to fend off hacks, a term substituted for the more controversial "countermeasures." The bill further clarifies that "defensive measures" does not include data that "destroys, renders unusable, or substantially harms an information system."
But privacy advocates were quick to again express dismay at the wording of several provisions in the latest iteration of CISA.
Jake Laperruque, a privacy and surveillance fellow at the Center for Democracy & Technology, said that, despite the revisions, CISA still amounted to a "cybersurveillance measure." Of particular concern, Laperruque said, was that the committee-passed legislation "required real-time 'insta-sharing' with the NSA" once data is handed over to the government—a mandated scheme that he said gained even more authority under the amended language.
When asked if the amended CISA bill fell short of privacy safeguards included in a separate bill introduced by Sen. Thomas Carper, Laperruque said "definitely." He noted that the measure from Carper, the top Democrat on the Senate Homeland Security Committee, gives no authority for countermeasures at all. Carper's bill adheres closely to a White House proposal rolled out in January.
The new CISA language also still allows for data collected by the government to be used for counterterrorism purposes, including thwarting the use of a weapon of mass destruction, although it restricts such use to imminent threats.
Privacy advocates' continued skepticism about CISA is unsurprising, given that Sen. Ron Wyden, a fierce civil-liberties hard-liner, cast the lone vote against the bill last week. The Oregon Democrat blasted the measure as "a surveillance bill by another name."
Sen. Dianne Feinstein, the panel's top Democrat, told reporters last week that 12 of 15 privacy amendments had been accepted by the committee either in part or full. Those changes should be enough to satisfy the bill's critics, she said.
"There has been misinformation about this bill, so let me be clear: The goal of the bill is for companies and the government to voluntarily share information about cybersecurity threats—NOT personal information—in order to better defend against attacks," Feinstein said in a Wednesday statement. "This bill includes more than a dozen significant changes from last year's version. The privacy provisions are substantial and I believe address many of the concerns that had been raised in regard to earlier drafts of the bill."
It is unclear how quickly the Senate intends to move CISA forward, but an aide to Majority Leader Mitch McConnell called information-sharing legislation a "priority." Senate Intelligence Committee Chairman Richard Burr indicated he believes the measure can earn a vote in early April.
Singapore Government to use VASCO Two-Factor Authentication to Secure Access to Online Government Services
Assurity Trusted Solutions will Enhance Security for Citizen Account Access with OneKey Authenticator Based on VASCO DIGIPASS 275
OAKBROOK TERRACE, Ill. and SINGAPORE, March 18, 2015 /PRNewswire/ -- VASCO Data Security International, Inc. (NASDAQ: VDSI), a global leader in authentication, electronic signatures, and identity management, announced today that Assurity Trusted Solutions (Assurity), a wholly-owned subsidiary of the InfoComm Development Authority of Singapore (IDA), has been selected by the Singapore government to provide SingPass users with the ability to secure their e-government transactions using a two-factor authenticator developed by VASCO.
A government bulk tender has been awarded to OneKey's issuer, Assurity, as part of a systems upgrade program. The OneKey authenticator, based on the VASCO DIGIPASS 275, offers three different two-factor authentication functions; one-time password (OTP), challenge response and transaction signing. These security functions add a proven extra layer of protection against hackers.
OneKey is designed to allow citizens to use a single cyber-security device for many service providers, both government and private. As soon as July of this year, SingPass users will have the option of using OneKey to secure their e-government transactions. In addition to the security features provided by OneKey, users may also elect to receive their OTP via SMS, depending on the security profile of the online government service.
"We are very pleased to be able to support Assurity Trusted Solution's mission of protecting Singapore citizens' access to government services," stated Jan Valcke, President and COO of VASCO Data Security. "One-time passwords are being used very effectively by many of the world's largest banks to protect transactions against the latest hacking attacks, so it is very smart to protect citizens using the same proven technology."
About VASCO
VASCO is the world leader in providing two-factor authentication and digital signature solutions to financial institutions. More than half of the Top 100 global banks rely on VASCO solutions to enhance security, protect mobile applications and meet regulatory requirements. VASCO also secures access to data and applications in the cloud, and provides tools for application developers to easily integrate security functions into their web-based and mobile applications. VASCO enables more than 10,000 customers in 100 countries to secure access, manage identities, verify transactions, and protect assets across financial, enterprise, E-commerce, government and healthcare markets. Learn more about VASCO at vasco.com and on Twitter, LinkedIn and Facebook.
For more information:
Corporate Communications
+1-847-370-1486 (US) or +32 2 609 97 00 (ROW)
pr@vasco.com
SOURCE VASCO Data Security International, Inc.
RELATED LINKS
http://www.vasco.com
I find the block tab works very well
Mizuho Bank of Japan now using VASCO authentication.
Earnings April 22, can we say short squeeze ??
Galileo Life Sciences, Inc. Imminent Health Canada license ?
MDRM 0.0249 + 37.57%
EAPH 49% stake ??? $$$$$$$
If only there was a way to ramp up production of ZMAPP. Hmmmm.
IBIO Inc. Short Interest Disclosure
Deanie Harlan Mar 12, 2015
iBio Inc., A rise of 160,038 shares or 14.2% was seen in the short interest of iBio Inc.. Even as the interest increased from 1,124,173 shares on February 13,2015 to 1,284,211 shares on February 27,2015, the days to cover came in at 3. The updated interest stood at 2.2% of the stocks floats. The counter has an average daily volume of 458,786 shares.
iBio, Inc. (NYSEMKT:IBIO) fell 6.12% or 0.045 points in the latest market session. The volatile session saw the price touching $0.735 on the upside and slid to $0.652 on the downside. However, the stock pared major losses and closed at $0.69. At the end of this see-saw battle, the volume was recorded at 1,512,269 shares. The previous close of the counter is $0.735. The stock has a 52-week high of $3.48 and the market cap of Nabors Industries is $51 million. The total number of shares outstanding is roughly 73,981,000. The 52-week low of the counter is $0.24.
iBio, Inc. (NYSEMKT:IBIO) has dropped 19% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 37.29% in the last 4 weeks. The counter has underperformed the S&P 500 by 17.7% during the past week but iBio, Inc. (NYSEMKT:IBIO) has outperformed the index in 4 weeks by 36.24%.
VASCO Data Security International, Inc. Short Interest Disclosure
MARCH 12, 2015 BY JOE WILLAMS
VASCO Data Security International, Inc. (NASDAQ:VDSI) has shown a rise of 34.4% or 2,117,502 shares in the short positions. The bets have increased to 8,270,302 shares on February 27,2015 from 6,152,800 shares on February 13,2015. With respect to the floated shares, the shorts are 29.1%. The counters days to cover are calculated to be 2, using the standard per day volume of 3,861,779 shares.
VASCO Data Security International, Inc. (NASDAQ:VDSI) turned north and gained 1.62% or 0.35 points for the day. Even as the stock dipped to $21.35 intraday, the bulls came into action and elevated the price to close at $21.89. The highest point of the day was $22.15. At the end of this positive session, the number of shares traded came in at 1,051,171. The shares had ended the previous session at $21.54. The 52-week high of the stock is $31.84 and the company has a market cap of $868 million. As per the recent update, the company has 39,667,000 shares in outstanding.
VASCO Data Security International, Inc. (NASDAQ:VDSI) has dropped 11.87% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 1.67% in the last 4 weeks. The counter has underperformed the S&P 500 by 10.45% during the past week but VASCO Data Security International, Inc. (NASDAQ:VDSI) has outperformed the index in 4 weeks by 0.89%.
VASCO Data Security International, Inc. (NASDAQ:VDSI) announced the earnings results for Fiscal Year 2014 and Quarter 4. The results came in during pre-market on February 17,2015. Company reported revenue of $62.43 Million, above the estimates of $54.00 Million. The revenues were $8.43 Million or 15.6% above the estimates. Earnings per share were $0.32.The reported EPS was above estimates by $0.12 or 60 %. Analysts had estimated an EPS of $0.2.
VASCO Data Security International, Inc. (VASCO), through its operating subsidiaries, design, develop, market and support hardware and software security systems that manage and secure access to information assets. Those security systems include user authentication and public key infrastructure (PKI) products and services for employee and consumer security, e-business and e-commerce. The Company operates in two segments: authentication products and services. The target markets of the Company are banking and financial services market and the enterprise and application security market. On January 10, 2011, the Company acquired DigiNotar Holding B.V. and its subsidiaries and acquired 100% interest in DigiNotar B.V. and DigiNotar Notariaat B.V. (collectively, DigiNotar). In April 2011, the Company acquired Alfa & Ariss B.V. On September 20, 2011, its subsidiary, DigiNotar B.V., filed a voluntary bankruptcy petition. In May 2013, the Company acquired Cronto, of Cambridge.
New EBOLA cases in the UK.
Daily Mail.com
PUBLISHED: 11:58 EST, 11 March 2015 | UPDATED: 11:30 EST, 12 March 2015
Female nurse working at British-run treatment centre has tested positive
She is the first member of British Armed Forces to be diagnosed with Ebola
She has been transferred for treatment at Royal Free hospital under guard
Four more Britons including female RAF medic were also tested for Ebola
Medics are also looking into how she was exposed to the deadly disease
By LARISSA BROWN, DEFENCE CORRESPONDENT FOR THE DAILY MAIL and AMANDA WILLIAMS and STEPH COCKROFT FOR MAILONLINE
A British Army nurse who has been diagnosed with Ebola has been flown back to the UK for specialist treatment, alongside two of her colleagues who could have contracted the disease.
A specially-equipped RAF C17 aircraft was last night dispatched to Sierra Leone to take the female nurse and her fellow medics for treatment at Royal Free hospital in London, the only place in the country equipped to handle highly infectious diseases.
Dramatic scenes captured the moment the RAF plane, which has also brought back two of the female worker's colleagues for further monitoring, touched down at RAF Northolt in west London just before 2pm.
The three were then rushed by police escort to the Royal Free Hospital (RFH) in London where the infected worker will be treated at its special high-level isolation unit.
A further two workers who may have come into contact with the disease remain in Sierra Leone and will be kept under observation there while a decision is made about whether to bring them to the UK.
Scroll down for video
100%
Claims involve human monoclonal antibodies specifically recognizing the Protective Antigen (PA) or the Lethal Factor (LF) of Bacillus anthracis, the bacteria causing anthrax. In mouse and non-human primate studies such antibodies, produced with the use of iBio’s iBioLaunch™ gene expression platform technology, prevented death in 100% of animals given an otherwise lethal doses of anthrax spores.
“A non-glycosylated version of this antibody binds PA, neutralizes anthrax LeTx activity in vitro and possesses superior efficacy contrast with the glycosylated form of this antibody in non-human primates — a significantly longer half-life and 100% protection against a lethal dose of aerosolized anthrax spore challenge after a single i.v. administration,” said Terence Ryan, Ph.D., Chief Scientific Officer of iBio. “These results suggest that this monoclonal antibody may be a useful tool for the treatment of inhalation anthrax in humans.”
iBio, Inc., a biotechnology corporation, focuses on the commercialization of its proprietary plant-based protein expression technologies in the United States and internationally.
03/03/15 - 09:50 AM EST
Trade-Ideas LLC identified Vasco Data Security International ( VDSI) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Vasco Data Security International as such a stock due to the following factors:
VDSI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $91.3 million.
VDSI has traded 123,490 shares today.
VDSI is up 3.3% today.
VDSI was down 8.9% yesterday.
More details on VDSI:
VASCO Data Security International, Inc., together with its subsidiaries, designs, develops, and markets security systems to secure and manage access to user digital assets worldwide. VDSI has a PE ratio of 26.1. Currently there are 2 analysts that rate Vasco Data Security International a buy, no analysts rate it a sell, and none rate it a hold.
The average volume for Vasco Data Security International has been 1.4 million shares per day over the past 30 days. Vasco Data Security International has a market cap of $1.0 billion and is part of the technology sector and computer software & services industry. The stock has a beta of 1.57 and a short float of 20.9% with 1.62 days to cover. Shares are down 17.3% year-to-date as of the close of trading on Monday.
TheStreet Quant Ratings rates Vasco Data Security International as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.
Highlights from the ratings report include:
The revenue growth greatly exceeded the industry average of 10.3%. Since the same quarter one year prior, revenues rose by 44.3%. Growth in the company's revenue appears to have helped boost the earnings per share.
VDSI has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 3.70, which clearly demonstrates the ability to cover short-term cash needs.
Current return on equity exceeded its ROE from the same quarter one year prior. This is a clear sign of strength within the company. Compared to other companies in the Software industry and the overall market, VASCO DATA SEC INTL INC's return on equity exceeds that of both the industry average and the S&P 500.
Powered by its strong earnings growth of 211.11% and other important driving factors, this stock has surged by 220.77% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, although almost any stock can fall in a broad market decline, VDSI should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
I like VDSI here. Imo once the % of shorts declines and next quarter reports @$ 35. to 38?
Not to mention the possibility of an epic short squeeze to the mid 40's
Bipartisan common sense? Is it Thursday in DC already?
A bipartisan bill introduced in the House of Representatives Tuesday would allow Department of Veterans Affairs doctors to recommend medical marijuana to military veterans in states where it is legal.
The Veterans Equal Access Act would allow VA doctors to recommend or offer opinions about medical marijuana for veterans suffering from serious injuries or chronic conditions like post-traumatic stress disorder. VA doctors are currently prohibited from aiding patients seeking medical use of marijuana.
“Post-traumatic stress and traumatic brain injury can be more damaging and harmful than injuries that are visible from the outside,” said Rep. Earl Blumenauer (D-Ore.), a co-sponsor of the bill. “And they can have a devastating effect on a veteran’s family. We should be allowing these wounded veterans access to the medicine that will help them survive and thrive, including medical marijuana -- not treating them like criminals and forcing them into the shadows. It’s shameful.”
Nearly 30 percent of veterans who served in the Iraq and Afghanistan wars suffer from PTSD and depression, according to a 2012 VA report. Some research has suggested marijuana may help PTSD symptoms, which can include anxiety, flashbacks and depression. A recent study found that PTSD symptoms in patients who smoked cannabis were reduced an average of 75 percent.
Other co-sponsors of the bill include Reps. Sam Farr (D-Calif.), Jared Polis (D-Colo.), Dina Titus (D-Nev.), Justin Amash (R-Mich.), Richard Hanna (R-N.Y.), Walter Jones (R-N.C.), Tom Reed (R-N.Y.), and Dana Rohrabacher (R-Calif.).
Currently, 23 states allow the medical use of marijuana. Ten of those states, as well as Guam, allow doctors to recommend medical marijuana for PTSD-related symptoms. The plant remains illegal under federal law for all uses.
“The men and women who served in Iraq and Afghanistan have made tremendous sacrifices for our country," said Dan Riffle, director of federal policies for Marijuana Policy Project. "They deserve every option available to treat their wounds, both visible and hidden."
ALSO ON HUFFPOST:
MMPR only a matter of time for EAPH.
Just read my prior post!
If any of you know anything about the future of MJ than you are aware that DABBING with vaporizers and edibles are the future.
I purchased a SNOOP DOGG G vape pen that's the f---ing Bomb
Snoop Dogg | microG Travel Kit™ from EASTON's ecigmarkets.com
$69.99> dare to compare. Here in Denver there are a lot of options and this beats the others at this price by far.
I was taking a bunch of poison for ptsd and nothing worked.
now I have total control over my issues with a simple HERB that I can eat or vape, different strains for time of day or type of symptoms.
Large pharma has the V.A. in their pocket and they are poisoning us with that shit they prescribe. so wake the f--- up and seize the moment. I for one bought the shit out EAPH and now that I can hold down a job as soon as get paid on Fri I hope I can pick some up at .0123 LO f---ing L. : ) time to DAB.
Alaska tomorrow, DC on Thursday
First Phase of Alaska Marijuana Legalization Goes Into Effect Tomorrow
Alaskans voted to legalize marijuana last November. That starts tomorrow, although pot commerce won't be coming for another year.
By Phillip Smith / AlterNet February 23, 2015
Print
COMMENTS
As of Tuesday, February 24, 2015, the first phase of Alaska's voter-approved Measure 2 marijuana legalization goes into effect. Beginning then, people 21 and over can legally possess up to an ounce of weed and grow up to six plants in their home (only three flowering). Adults may also share up to an ounce of weed with other adults and give them up to six plants.
Private pot-smoking will be completely legal for adults, although public consumption remains illegal. Not all issues related to personal use, possession, and cultivation are resolved. The state legislature is still trying to settle questions around, edibles, transporting marijuana, and use by minors. Senate Bill 30, which was supposed to be ready by legalization day, is still working its way through the legislature.
The second phase of legalization—legal, taxed, and regulated marijuana commerce—won't go into effect until the spring or summer of 2016. A nine-month rulemaking process is set to begin on legalization day, with the state expected to begin accepting applications for business permits in February 2016. The timeline was mandated in Measure 2, and the process is on schedule so far.
"First Colorado and Washington, now Alaska and Oregon – and all with levels of support higher than the winning candidates for governor and U.S. Senate achieved in those states," said Ethan Nadelmann, executive director of the Drug Policy Alliance. “Legalizing marijuana just makes sense now to voters across the political spectrum and – as we’ll likely see in 2016 – across the country."
Dr. Tim Hunterberger, cosponsor of the initiative and chair of the winning Campaign to Regulate Like Alcohol in Alaska, and Bruce Schulte of the Coalition for Responsible Cannabis Legislation, an industry group monitoring the implementation process, are calling for legalization supporters to celebrate by consuming marijuana responsibly and to keep in mind that personal legalization doesn't mean a marijuana free-for-all.
"As with alcohol there’s an appropriate time, place, and manner to consume marijuana, and the worst thing that could happen right now is for a handful of overzealous folks to spoil things by making a public spectacle out of marijuana consumption," they cautioned. "So, please be respectful of your fellow Alaskans, don’t drive under the influence and don’t do anything to give your neighbors reason to feel uneasy about this new law. We’re in the midst of an enormous social and legal shift. Please do your part to make it as successful as possible by consuming responsibly."
Alaska isn't the only place where legalization is going at least partially into effect this week. The District of Columbia's pot possession and cultivation legalization initiative is set to go into effect Thursday—unless Congress miraculously acts to block it (and the president signs such a measure) before then.
Phillip Smith is editor of the AlterNet Drug Reporter and author of the Drug War Chronicle.
Check out the % of short interest. IMO with the right catalist the short squeeze should be epic. In at @19. Out at 30.85. Back in at 22.5 out at ? 38. :)
Just a matter of time for EAPH :)
Medical Marijuana Update: Bedrocan gets MMPR.
Canadian/Dutch medicinal cannabis power players Bedrocan (TSX:V.BED, Stock Forum) have received notification that their second site has been greenlit by Health Canada for growing.
The information follows a trade halt a few hours ago (at the time of writing) and, though the MMPR approval is for production only, by my reading of things it will allow the company to sell through its existing MMPR, much as Tweed does with ‘production only’ approved Tweed Farms.
Approval of their facility has been the sole missing piece of the Bedrocan business plan to date, and will allow the company to begin offering its clients locally produced product, rather than the imported product previously brought in from its Dutch parent.
The move will also bring down base costs, help the company greatly expand its patient base, and lock down supply; an important benefit, as Bedrocan currently supplies much of Europe with its medicinal cannabis and could only spare so much for Canadians previously.
Also joining the production MMPR list is Alberta’s Aurora Medical Marijuana. CannTrust, a pharmacist-owned outfit in Vaughan Ontario, has been added to the licensed to sell list, which now features 16 companies. Ten companies are listed on the production only list.
This activity demonstrates that there has been no halt to the Health Canada licensing process, despite industry assumptions that regulatory bureaucrats could be waiting until after the upcoming court injunction on ending the old MMAR system has been dealt with.
Aurora comes on as Alberta’s sole representative on the list.
The perhaps bigger piece of this news is the thawing it has brought the market has a whole. With so many investors assuming the taps were turned off for the foreseeable future at Health Canada, the new licenses demonstrate the opposite to be the case.
Supreme Pharmaceuticals (CSE:C.SL, Stock Forum), which is waiting for its final inspection, jumped 22.7% on the licensing news.
Much to the relief of just about everyone in the Canadian MMJ space, Creative Edge Nutrition (OTO:FITX, Stock Forum) has been officially told it will be rejected for a license, according to a Health Canada spokesman speaking to the Globe and Mail, CTV, and the CBC, and has 20 days to appeal that decision.
The company, which is an outrageous and obvious pump and dump of the most blatant and fraudulent order, lost 40% of its value on the news, while some cultists bagholders continue to believe it’s all just a put-on, accusing the HC spokesman of being a hoax, and worse while claiming the media and political parties and bloggers (and me) are all in on the fix.
A company shareholder update posted today didn’t mention the words ‘rejected’ at all, instead phrasing it that the company “is pleased to announce it has been asked to provide additional information to Health Canada in support of its application.”
The update also cast aspersions on Health Canada staff for discussing the issue with the press, saying it has contacted the Office of the Privacy Commissioner on the matter.
The new CEO of the company announced last week (with a vintage CEN news release that makes a variety of outrageous and lofty unverified claims) that it will now dominate the energy drink market. And has lined up a ton of celebrities. And that focus groups think the product is all sorts of awesomez. Stock has risen 25% since because some penny stock investors are touched in the head.
True Leaf Medicine (CSE:C.MJ, Stock Forum) went public last week, with a nice MMJ-focused ticker symbol and two applications in the pipeline. The company has an application in for a 48k sq. ft. growing facility in Lumby B.C., and is chaired by former B.C. Premier and Vancouver Mayor Mike Harcourt.
You may recall Harcourt had previously been associated with Vodis Pharmaceuticals (CSE:C.VP, Stock Forum), earning 250k shares in the company before saying they “don’t know s–t from shinola about business,” in the press.
Trueleaf made its first application for an MMPR approval back in July 2013, and received a Ready To Build for its first facility back in January 2014. A second application for facility #2 was lodged in April of that year. The stock opened at $0.14 and has since backslid to $0.11 on light volume.
InMed Pharmaceuticals (CSE:C.IN, Stock Forum), formerly Cannabis Technologies, has been eating its Wheaties of late, rocketing up from as low as $0.12 in late January to $0.30 today, on the back of continued good news out of its research activities.
The company has added INM-750 to its therapy roster, this one used for the treatment of Epidermolysis Bullosa Simplex (EBS), a rare skin disorder The company is moving to pre-clinical trials of the treatment and add to its existing glaucoma and arthritis therapies.
Mettrum (TSX:V.MT, Stock Forum) announced Q3 results, bringing in $689k in revs on nearly 100k grams sold at an average of $7.28 per. $1.3m in losses on 2200 clients. They’re also moving into the consumer products space, grabbing Hempola, a hemp producer, for $250k and 15% of the company EBIDTA annually for the next five years.
Tweed (TSX:V.TWD, Stock Forum) also released financial info yesterday, pushing them up 8%. Q4 revs were $641k with $357k of that in December. Orders are reportedly being turned around quickly. Whether those orders include product from the chocolate factory or elsewhere, I can’t say. But it’s good revenue is growing.. the industry at large needs it’s most prominent player to demonstrate viability.
Ontario-based health clinic play MedCannAccess is, I hear, orchestrating a deal. Watch this space.
Read more at http://www.stockhouse.com/news/newswire/2015/02/19/medical-marijuana-update-bedrocan-gets-mmpr-inmed-on-tear#RdOzZeGPu0sUv83o.99
Notice of a proposed settlement was filed February 9, 2015 with the U.S. District Court
SEATTLE, Feb 12, 2015 (BUSINESS WIRE) -- GrowLife, Inc. (otcmkts:PHOT) announced today that on February 9, 2015, the Company and plaintiff’s counsel filed a Notice of Proposed Settlement with the Court presiding over the Consolidated Class Action lawsuits filed in 2014. The parties expect to file Notices of Proposed Settlement in the Court presiding over the Derivative Actions during February, 2015. The Company anticipates that the settlements will be documented and any necessary motions for Court approval of the settlements will be filed within the next 45 days.
For more information about GrowLife, please visit: www.growlifeinc.com. Additional commentary on the Company as well as the industry is also provided on Mr. Hegyi’s blog.
No lead plaintiffs . Lawsuits all bogus perpetuated by shorts.
About PHOTking time.
EAPH AND MEDICATED MARKETS, LOOKING FORWARD LONG TO PROFITABLE PARTNERSHIP.
Medicated Markets Medicated Markets
Skip to content
Shop
?
Snoop Dogg | microG Herbal™
SALE!boxclosed-3_grande
$179.99 $149.99
Introducing the Snoop Dogg | microG Herbal™, the 2nd installment in the Double G Series, a collection of personal vaporizers designed by Snoop Dogg, himself.
I am an independent investor and this is not in any way meant as trading advise.
form free site American Bulls.
EAPH EASTON PHARMACEUTICALS 12/23/14
Signal:BUY
Pattern:BULLISH HARAMI CROSS
Last Close:0.0113 Change:+0.0023 Percent change+25.56%
recommendation today is to BUY. The BULLISH HARAMI CROSS pattern finally received a confirmation because the prices crossed above the confirmation level which was at 0.0108, and our valid average buying price stands now at 0.0109. The previous SELL signal was issued on 12/2/2014, 21 days ago, when the stock price was 0.0131. Since then EAPH has fallen by -16.79%.Market Outlook , may be at a market bottom or at the start of a reaction rally. Today’s candlestick has a white body and its close is above the confirmation level. The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated.
Pattern Description This is a major bullish reversal pattern, which is even more significant than a regular Bullish Harami.
I will search for it, I first received the info as a subscriber to 420 I which I no longer am, but I did find this and I will be changing my handle WOMS. At the bottom there are some good links.
PHOT Growlife stock just got halted this morning by the SEC. According to an alert by Tim Sykes, PHOT was halted due to stock manipulation. You might be wondering why I am sharing this news especially if you don’t trade stocks yet, know nothing about the weed sector or Tim Sykes. Well there is a very good reason for me sharing this information.
For the last several weeks Tim Sykes has been exposing a very lucky (& half a million dollars richer) newbie trader (or stock pumper) called the Wolf of Weed Street.
Who?
“I trade mainly on sentiment & leave the more technical aspects to other Wolves, but I do chart. I have a group of traders that pool resources & $$$ to make the #Wolf-Fund. My persona on twitter @wolfofweedstreet only discusses Marijuana related stocks. I Am the Wolf of Weed Street and while I love profits, I hate scammy companies that trade on over hyped pr’s 3x a week and Unicorn farts. I am here to bring balance to the #MMJ universe…But always do your own DD and invest wisely.”
That’s who.
The responses to Tim from fans of the Wolf pack have been the ugliest of the ugliest. People have called him everything from a LIAR to a C–KSUCKER. (much much worse but I am a family man now so…)
You see Mr. Sykes loves to expose stock pumpers and the Wolf of Weed Street fits the pumper profile. The Wolf is a man (nobody knows exactly) who has built up a cult following by sending out free HOT stock picks related to the weed sector. People have made a significant amount of money in a very short amount of time because of his alerts. On the contrary some people have lost a significant amount of money as well. However, Tim has always felt that this was stock manipulation at its worst. Some have called Tim jealous of the Wolf and others have said he was taking advantage of a marketing ploy by exposing Mr. Wolf so aggressively.
Watching this all unfold while I go through my millionaire challenge journey has been an amazing real life lesson. It has taught me about the ugliness of the stock market. It has taught me that you must do your own investigating of all sides. It has taught me to be careful of sheep in wolves clothing. No pun intended. Lastly, it has also taught me that posts like these are a great way for me to share with you the things that you will learn about as a Tim Sykes’ student.
WOW WHAT AN EDUCATION!!!
Anyway, although there is no evidence that the Wolf of Weed Street is the reason the SEC halted PHOT today it is interesting to note 3 things.
It’s in the same sector he promotes.
All of the Wolf’s weed picks have gotten crushed lately.
You can no longer view the Wolf of Weed Street’s tweets as they are now protected.
It might not be the Wolf but it might be someone from the wolf pack. Hmmmm.
To learn more about what Tim Sykes has said about the Wolf of Weed Street please click here.
To read what the SEC has said about PHOT please click here.
Update – It just keeps getting better. Tim Sykes and the Wolf of Weed Street spoke for a half hour over the phone and Tim apologized for his passionate harsh words. You can read the post by Tim here.
Jail for sure. From my post I hope you gathered that the crooks took it upon themselves to target PHOT and others. Its all in the SEC's report about halting PHOT. Even 420 investor Alan Brochstein was blind sighted by this one.
Staying long, no choice while its a GREY.
Nov 20, 2014 14:00 UTC
GrowLife Announced Revenues of $2.1 Million for Third Quarter Ending September 30, 2014
SEATTLE--(Business Wire)--GrowLife, Inc. (OTC:PHOT), one of the largest cultivation service providers in the nation, reported today in its latest financial statement revenues of $2.1 million for the third quarter ending on September 30, 2014. GrowLife also reported gross margins were (8.5%), resulting from the Company’s decision to convert its high inventory level of $1.8 million from last quarter to working capital and reduce ending inventory at $800,000. General and administrative expenses were $1.9 million for the quarter, which included approximately $1.1 million in non-cash stock expenses.
“Our third quarter revenues delivered an impressive 60 percent growth compared to this time last year, which is when we first recognized revenue from major retail acquisition that occurred in June 2013,” said Marco Hegyi, President of GrowLife, Inc. “As we continue to work through challenges such as limited access to capital due to gray market trading and lawsuits, which are in negotiations, we elected to convert about three month’s of inventory into cash while optimizing sales.”
Mr. Hegyi, who assumed leadership over the Company in the second quarter 2014, has reduced operational expenses while increasing revenue. The Company has achieved record revenue of $6.7 million in the first nine months of 2014 over last year’s $2.9 million, representing 131% growth.
“Our solid revenue is attributed to customers and management who have remained confident in our future,” said Hegyi. “The Company’s growth is now moving closer to critical mass, where gross profit will offset expenses, and move us towards profitability.”
Noteworthy details from today’s extensive quarterly report are as follows:
Q3 2014 Highlights
Net revenue for the three months ended September 30, 2014 increased $792,000 to $2,105,000 as compared to $1,313,000 for the three months ended September 30, 2013.
Gross margin was $(179,000) as compared to $262,000 for the three months September 30, 2013.
The gross margin was (8.5%) for the three months ended September 30, 2014 as compared to 19.9% for the three months ended September 30, 2013. The decrease was due to selling our products at a higher discount and the liquidation of inventory at lower margins during the three months ended September 30, 2014.
General and administrative expenses for the three months ended September 30, 2014 increased $633,000 to $1,923,000 as compared to $1,290,000 for the three months ended September 30, 2013. Non-cash general and administrative expenses for the three months ended September 30, 2014 totaled $1,062,000.
Other expense for the three months ended September 30, 2014 was $35,664,000 as compared to other expense of $777,000 for the three months ended September 30, 2013. The expenses for the three months ended September 30, 2014 included loss on change – derivative liability warrants of $6,949,000 and interest expense of $28,715,000.
Net loss for the three months ended September 30, 2014 was $37,766,000 as compared to a net loss of $1,805,000 for the three months ended September 30, 2013 for the reasons discussed above.
Our cash used in operations for the three months ended September 30, 2014 was $411,000.
YTD 2014 Highlights
Net revenue for the nine months ended September 30, 2014 increased $3,806,000 to $6,745,000 as compared to $2,939,000 for the nine months ended September 30, 2013.
Cost of sales for the nine months ended September 30, 2014 increased $3,654,000 to $5,903,000 as compared to $2,249,000 for the nine months ended September 30, 2013.
Gross margin was $842,000 as compared to $690,000 for the nine months September 30, 2013. The gross margin was 12.5% for the nine months ended September 30, 2014 as compared to 23.5% for the nine months ended September 30, 2013.
General and administrative expenses for the nine months ended September 30, 2014 increased $3,138,000 to $6,684,000 as compared to $3,546,000 for the nine months ended September 30, 2013. Non-cash general and administrative expenses for the nine months ended September 30, 2014 totaled $3,359,000.
Our cash used in operations for the nine months ending on September 30, 2014 was $1,979,000.
GrowLife implemented additional changes to its business operations that were reflected in the third quarter, such as payroll, rent and other expense reductions, comprehensive market coverage, and the consolidation of disparate business divisions. These critical changes should be more apparent in the three months ended December 31, 2014.
For more information about GrowLife, please visit: www.growlifeinc.com. Additional commentary on the Company as well as the industry is also provided on Mr. Hegyi’s blog.
About GrowLife, Inc.
GrowLife, Inc. (PHOT) (www.growlifeinc.com) aims to become the nation’s largest cultivation service provider for cultivating organics, herbs and greens and plant-based medicines. Our mission is to best serve more cultivators in the design, build-out and expansion of their facilities with products of high quality, exceptional value and competitive price. Through a nationwide network of local representative, regional centers and its e-Commerce team, GrowLife provides essential goods and services including media (farming soil), industry-leading hydroponics equipment, plant nutrients, and thousands more products to specialty grow operations in 17 states. GrowLife is headquartered in Seattle, WA and was founded in 2012.
Cautionary Language Concerning Forward-Looking Statements
This release contains "forward-looking statements" that include information relating to future events and future financial and operating performance. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for GrowLife's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in GrowLife's filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include statements regarding future sales, costs and market acceptance of products as well as regulatory actions at the State or Federal level. For a more detailed description of the risk factors and uncertainties affecting GrowLife, Inc. please refer to the Company's Securities and Exchange Commission filings, which are available at www.sec.gov. GrowLife, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
GrowLife, Inc.
Media Relations:
Tina Qunell, 206-919-9652
GrowLife Communication Team
tina@growlifeinc.com
or
Investor Relations:
Tina Qunell, 206-919-9652
Shareholders Support Team
tina@growlifeinc.com
The 10-day trading halt in April, followed by charges brought against four individuals for stock manipulation, unaffiliated with GrowLife, has had a profound and lasting impact on GrowLife as well other publicly-traded companies operating in the Cannabis-related industry. We have spent considerable effort to resolve these matters, working closely with the SEC and FINRA, to restore financial equilibrium for our Company and its shareholders.
GrowLife has also emphasized customers, and took many strategic steps to best serve cultivators across the nation. We have strengthened our distribution power to provide a wide range of opportunities to customers, improved business fundamentals, and resolved legacy issues. As a result, we’ve reached record sales for 2014, serving more than 1 million square feet of operations with hydroponic equipment, lighting, nutrients, soil and supplies.
Despite our sales growth, our stock price remains highly volatile given that we’re trading in the greys. We trust the process we have in place will get us back to active trading, however, I understand there are still a litany of questions and concerns. I wanted to personally address some of the questions we’ve received from shareholders either in email or on the Company’s Facebook page in an effort to help shed some light on our situation. Please keep in mind that while there is much discussion from shareholders, it is our customers, suppliers and employees that are critical to the Company’s growth.
Is it likely or unlikely GrowLife will obtain a market maker?
Yes, we’re confident the Company will secure a market maker. While there are many market makers interested in participating, there is a significant downside risk to the first one that applies for the 15c2–11. Therefore, an interested broker-dealer must do extensive due diligence in the Company before applying to FINRA with the 15c2–11. Then, FINRA must thoroughly review and, if approved, will reintroduce liquidity in the stock.
What reason does an investor have to stay around?
As with any stock trading on the OTC Bulletin Board, the risks are extremely high and returns on these investments, if any, could take years to recognize?—?even with all the careful consideration and due diligence by an investor. Investors considering GrowLife need to be willing to have confidence in our long game, and clearly see both the opportunities and risks. Unfortunately, some investors are short-sighted, and those who know me are aware of my feelings towards these people. These Short traders bet against both the Company and the Long investors resulting in great volitility in the stock price. When the stock price is low, as it normally is for OTC stocks, the swings can create double-digit gains in just a few days. It’s a reality but I am not a big fan.
I hope to see GrowLife uplist and provide stability that will discourage such predatory behavior so that the Company, on average, is valued on its business performance instead of the Buy-at-$0.10-Sell-at-$0.12 short mentality. I know that many of our current shareholders are from this camp but in time I hope to convince those shareholders to move GrowLife from their short sale portfolio segment to their long-term segment. My plan is to have GrowLife earn that position in their portfolio.
Allow me to speak about the current Long investors who have a deep appreciation for strong financial controls and business fundamentals over daily trade gains or losses. They stay because they trust GrowLife will inevitably become a huge and true success in this industry, appreciate the steps we have taken so far, and most important to me, trust us to achieve our vision as a leading and lasting partner to cultivators.
How will GrowLife deal with competitors? In other words, what does the business plan look like?
Our customers come to us because we have an experienced and knowledgeable team who work with them to help manage build-out investments, track supply usage and streamline their supply chain needs. Many, therefore, compare us to the ‘picks and shovels’ sold to miners during the gold rush, but that is a small part of the story.
Picks and shovels was a retail play for miners and is ridiculously simplistic. GrowLife’s mission is far greater as we serve cultivators who have an expensive crop for human consumption; I really hate the picks comparison. Our supplies, equipment and services enable cultivators to grow crops that ensure their operations meet compliance standards and produce medicinal crops that are safe for consumption. Comparing our business to picks and shovels dismisses patients who consume these crops.
On another note, we also help cultivators identify products that can reduce their carbon footprint and conserves vital resources, such as water and electricity. This is an area where we will be more actively involved starting this quarter. Few of our competitors take this long view.
How much of your predecessor’s claims still ring true and are still a possibility? i.e., partnerships, GIFT, kiosks, etc. Granted you have so much more to gain by being successful, but how can you assure your investors that you’re not just out to sell shares and shut down the company?
I see GrowLife as a dramatically different Company than it was before. For example, partnerships and claims that make business sense will be pursued, others will not. GrowLife is about its customers and helping them serve their customers. No one can be everything to everyone without sacraficing quality and GrowLife is about quality. I’ve seen it in the tech industry where the leaders offer dozens of products but it’s usually their top two or three that make up 80%+ of the business because that’s what matters.
In GrowLife’s case, we serve cultivators with equipment, supplies and services. We’re not a bank so financing, ATM kiosks, etc. were tested concepts that are off the table. I see our customers as Commercial Cultivators, Urban Farmers, and Home Growers. Although we have five retail stores, I believe that our other sales channels?—?eCommerce, direct sales, and distribution?—?will eclipse our retail business. GrowLife may best serve the industry by helping other retailers address Urban Farmers and Home Growers.
As for your second question, my short answer is that if you believe in a company, then invest in it. If you don’t, then don’t. I would not invest in a company that I do not trust. I didn’t come here to fix a company; I came here to grow an industry. It just so happens that, for whatever reason, things broke in the industry and fixing has become the priority. I hope to get past this fixing distraction soon and focus on building.
There are so many cool things that I see coming out of this new cultivation industry beyond legalization: Smart growing technologies, cleaner and healthier ways to control our food supply in an affordable manner, the economic engine behind a crop that provides undiscovered medicinal benefits without insane side effects, a new entrepreneurial segment that rewards and validates a healthier lifestyle, and a crop that funds all this innovation without tapping our already depleated government funds; Not to mention the crime reduction benefits.
You recently promoted Joseph Barnes to Senior VP. Can you tell us more about him?
When I took charge of the Company in May I zero-based it, including every employee. I decided that we were going to either have the best people or have open positions, but we were not going to compromise the Company. Joe has been with our Hydroponics subsiduary for about five years; four years before it was merged with GrowLife. I stack ranked our organization and found him not only consistently number one but a solid leader who puts the business and his team before himself.
Joe leads a team responsible for serving cultivators across the nation. He also strengthens our distribution power so that our customers can have access to premium cultivation equipment and supplies that are good for the plants and people at the best possible price. The Company is fortunate to have him on the team. I promoted him to Senior Vice-President of Business Development to head up all our sales channels because he is the best both inside and outside of GrowLife.
Recommendation (today)12/17/14 is to BUY. The BULLISH DOJI STAR pattern finally received a confirmation because the prices crossed above the confirmation level which was at 0.6400, and a valid average buying price stands now at 0.6418.
https://www.americanbulls.com/DXB.axd?lang=en&Ticker=IBIO&DXCache=841766eb-b4b9-48b0-8cfd-4998f8009d06
My posts are my opinions only. I am not a financial adviser, do not trade or make decisions based on my posts
Not My Charts. Free site American Bulls. there are many others. I do however recommend a paid service for answers to your questions.
Patience and up to date info required for investing or trading
IBIO>
The 3-month chart of IBIO above graphically displays that a BULLISH HARAMI CROSS pattern is detected. BULLISH HARAMI CROSS pattern has a 66.67% chance of confirmation and a 83.33% probability of leading to a profitable trade in case of confirmation. The upside potential of the pattern is 11.33%. IBIO is a highly rated stock (5?) in our system and the BULLISH HARAMI CROSS pattern is one of its most successful bullish patterns. The intraday status of this stock must be monitored closely.In case of a confirmation, short positions must be immediately covered.
surfr1944 has been dead on, gotta give'm that.
I believe surfer called it weeks ago at .64
Maybe so, but this SnoopDog G vaporizer is da bomb. portable and easy to use as advertised.
Started a $ 1k position this am , lets see what happens.
Added to my IBIO position under .70 yeaaaahhhhh.
I like other serious investors have done my DD.
Bought more on Fri, sold other positions to buy any dips today.
IMHO IBIO is going to do very well . Looking forward to 2-4 Q 2015
ON THE NORTHERN FRONT
Health Canada
www.sc-hc.gc.ca
Skip to content | Skip to institutional links
English
Welcome
Contact us
Help
Research
Canada.ca
Home > Drugs and Health Products > Use of marijuana for medical purposes
Back to
Use of marijuana for medical purposes
Explore ...
Main Menu
Site Map
Healthy Canadians
Media Room
Transparency
Transparency and Regulatory opening
Requests for access to information Completed
Disclosure
Drugs and Health Products
Print | Text size: P M G TG Help | Share
List of authorized producers under the Regulations marihuana for medical purposes
Some hyperlinks are to sites of organizations that are not subject to the Official Languages ??Act . The material found there is therefore in the language of the site.This link will take you to another website
The table below contains the list of producers authorized under MMFN. The list is in alphabetical order.
Authorized producers can produce and sell dried marijuana
Name of authorized producer Phone number Email (if applicable) Website (if applicable)
Bedrocan Canada Inc. 1-855-420-7887 info@bedrocan.ca This link will take you to another website Bedrocan [in English only]
Broken Coast Cannabis Ltd. 1-855-488-3668 info@brokencoast.ca This link will take you to another website Broken Coast [in English only]
Canna Farms Ltd. 1-855-882-0988 info@cannafarms.ca This link will take you to another website Canna Farms [in English only]
CanniMed Ltd. 1-855-787-1577 info@cannimed.com This link will take you to another website CanniMed
Delta 9 Bio-Tech Inc. 1-855-245-1259 info@delta9.ca This link will take you to another website Delta 9 Bio-Tech Inc. [in English only]
In The Zone Produce Ltd. 1-800-420-1707 info@inthezoneproduce.com This link will take you to another website In The Zone Produce Ltd.
Mettrum Ltd. 1-844-638-8786 (METTRUM) info@mettrum.com This link will take you to another website Mettrum Ltd.
MedReleaf Corp. 1-855-4-Releaf (73-5323) askus@medreleaf.com This link will take you to another website MedReleaf Corp. [in English only]
ORGANIGRAM Inc. 1-855-961-9420 info@organigram.ca This link will take you to another website ORGANIGRAM Inc.
The Peace Project Naturals Inc. 1888 64-PEACE (73223) info@peacenaturals.com This link will take you to another website The Peace Naturals [in English only]
Tilray 1-844-TILRAY1 (845-7291) tilray@tilray.ca This link will take you to another website Tilray
Tweed Inc. 1-855-55-TWEED (89333) hi@tweed.com This link will take you to another website Tweed
Whistler Medical Marijuana Corp. 1-604-962-3440 info@whistlermedicalmarijuana.com This link will take you to another website Whistler Medical Marijuana Corp. [in English only]
Authorized producers are only allowed to grow marijuana
ABcann Medicinals Inc.
Aphria
CannMedica Pharma Inc.
Maricann Inc.
Prairie Plant Systems Inc.
RedeCan Pharm
Thunderbird Biomedical Inc.
Tweed Farms Inc.
167151 Canada Inc. / Medical Marihuana
Please check this Web site for updated information.
Marijuana for medical purposes - Promotion and producers authorized
November 25, 2014, Health Canada has sent warning letters to 20 producers authorized about their promotion practices.
These warning letters give following a release on advertising sent to all producers authorized 30 June 2014 which were described in the general prohibitions of the Regulations marihuana for medical purposes (MMFN), the Food Act and Drugs (FDA) and the Narcotic Control Regulations (SR) in promoting cannabis.
Because of these restrictions, the information provided to the public by licensed producers should be limited to basic information for potential customers, such as brand name, common name of the strain, Price, cannabinoid content and company contact information.
Authorized producers listed below have until 12 January 2015 to comply with the promotion requirements. Subsequently, Health Canada will take the implementing measures required as needed. Health Canada will update this list as the authorized producers demonstrate their compliance.
Customers should be aware that licensed producers who do not comply with the provisions of the FDA or the RS may be subject to enforcement measures of the law, including the suspension and eventual revocation of the license or prosecution .dropoff window
Authorized producers who received a warning letter from Health Canada
The companies below have received a warning letter and have until 12 January 2015 to comply with the regulations.
ABcann Medicinals Inc.
Aphria
Bedrocan Canada Inc.
Broken Coast Cannabis Ltd.
Canna Farms Ltd.
CannMedica Pharma Inc.
CanniMed Inc.
Delta 9 Bio-Tech Inc.
In the Zone Produce Ltd.
Maricann Inc.
MedReleaf Corp.
Mettrum Ltd.
ORGANIGRAM Inc.
Prairie Plant Systems Inc.
The Peace Project Naturals Inc.
Thunderbird Biomedical Inc.
Tilray
Tweed Inc.
Whistler Medical Marijuana Corp.
167151 Canada Inc. / Medical Marihuana
The hyperlinking to websites other than the Government of Canada
The hyperlinks to websites that are not managed by the Government of Canada, including those that lead to our social media accounts, are offered only for convenience to the visitors of our website. We assume no responsibility for the accuracy, currency or reliability of the content of these sites. The Government of Canada does not offer any guarantee in that regard is not responsible for the information found through these links and does not endorse or these sites or their content.
Visitors should also be aware that information offered by sites other than those of the Government of Canada, accessed via links from this website, is not subject to the Privacy Act of personal information or the Official Languages ??Act and may not be accessible to persons with disabilities. It may be that the information offered is available in the languages ??used by the sites in question. With respect to personal information, visitors are encouraged to consult the policies of these non-government websites in the protection of personal information before disclosing personal information.This link will take you to another website This link will take you to another website
Share
Reviews hyperlinks and Official Languages ??Act .
Email
Email
Hotmail
Gmail
Yahoo! Mail
Share this page
Twitter
Facebook
Delicious
Digg
Google Bookmarks
StumbleUpon
MySpace
reddit
Stay in touch with the social networking tools Health Canada! The Government of Canada does not endorse any particular site or social media tool.
11/26/14 -- Easton Pharmaceuticals (OTC: EAPH) has in the past month taken steps to enter into the fast growing Vaporizer market. On Black Friday and Cyber Monday we will be offering a 25% to 40% discount on select products. 25% discounts will apply for premium branded items while 40% will apply to non premium products. We believe there is adequate current inventory to satisfy anticipated demand, but selling out is always a possibility.
If any current shareholder wishes to purchase products we will extend a 10% additional coupon code: "Easton Tough." Have a Happy Thanksgiving and be safe by shopping from home at http://www.ecigmarkets.com/.
In addition to our Vaporizer venture we are committed to opening an initial flagship retail location and currently looking for suitable retail locations in the Metropolitan Greater Toronto area which is currently the 4th largest city in North America. Retail locations self advertise themselves and are currently a proven revenue generating model here in Toronto and the North East in general.
In the Canadian Medical Marijuana industry it would seem that positive developments have materialized whereby Health Canada has issued an MMPR license to Broken Coast Cannabis of British Columbia.
http://www.hc-sc.gc.ca/dhp-mps/marihuana/info/list-fra.php
If Health Canada has restarted issuing licenses for the fall/winter season Easton's Medical Marijuana joint venture initiative could be next on that list for inspection and licensing given it is one of the first to have applied and then received a letter to build from Health Canada under the new MMPR system.
CIO, CTO & Developer Resources
In additional Medical Marijuana related news, Easton continues discussions on two major medical marijuana markets, California and Colorado. More details on these discussions will be available by the second week of December. To provide more transparency to our shareholders, Easton has formulated partial disclosure agreements that will allow investors to have information as to the physical location and size of the grow pursuant to the completion of Due Diligence period.
DEC 23RD, are you by chance residing in Colorado ?:)